omni
aaps
US Approves First Drug for Psychosis Linked to Parkinson's
US Approves First Drug for Psychosis Linked to Parkinson's
Acadia Pharmaceuticals’s drug for psychosis linked to Parkinson’s disease was approved in the United States on Friday, becoming the first treatment for the condition to get a nod in the country. The U.S. Food and Drug Administration, howeve...
FDA Warns About Serious Heart Problems With High Doses of the Antidiarrheal Medicine Loperamide (...
FDA Warns About Serious Heart Problems With High Doses of the Antidiarrheal Medicine Loperamide (...
The U.S. Food and Drug Administration is warning that taking higher than recommended doses of the common over-the-counter (OTC) and prescription diarrhea medicine loperamide (Imodium), including through abuse or misuse of the product, can cause serious...
Pharmaceuticals Represent the Fastest-Growing Thermoform Packaging Segment
Pharmaceuticals Represent the Fastest-Growing Thermoform Packaging Segment
The pharmaceutical segment is estimated to be the fastest-growing thermoform segment in 2016, experiencing a higher growth rate than the food and beverage and electronics industries, primarily due to rising disposable incomes and an aging population.
Medicare's Drug-Pricing Experiment Stirs Opposition
Medicare's Drug-Pricing Experiment Stirs Opposition
A broad proposal by Medicare to change the way it pays for some drugs has drawn intense reaction and lobbying, with much of the debate centering on whether the plan gives too much power over drug prices to government regulators.
Synthetic Biology Bites Back at Global Snake Antivenom Shortage
Synthetic Biology Bites Back at Global Snake Antivenom Shortage
When the medical charity Médecins Sans Frontières called the worldwide shortage of snake antivenom a public-health crisis last September, Brazilian biochemist Paulo Lee Ho wasn’t surprised. He has spent his career at São Paulo̵...